Role of pharmacokinetics and metabolism in drug discovery and development

被引：2
作者：
Lin, JH [1 ]
Lu, AYH [1 ]
机构：
[1] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA
来源：
PHARMACOLOGICAL REVIEWS | 1997年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：403 / 449
页数：47
相关论文
共 494 条
[1]  
AARONS L, 1986, PHARM THEORY METHODO, P163
[2]   KINETICS OF DRUG DISPLACEMENT INTERACTIONS [J].
AARONS, LJ ;
ROWLAND, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (02) :181-190
[3]  
ABAS A, 1987, J PHARMACOL EXP THER, V240, P637
[4]   METHADONE PLASMA-PROTEIN BINDING - ALTERATIONS IN CANCER AND DISPLACEMENT FROM ALPHA-ACID GLYCOPROTEIN [J].
ABRAMSON, FP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (05) :652-658
[5]  
ABRAMSON FP, 1991, PLASMA BINDING DRUGS, P57
[6]   PHARMACOLOGICAL DIFFERENCES BETWEEN OPTICAL ISOMERS OF IBUPROFEN - EVIDENCE FOR METABOLIC INVERSION OF (-)-ISOMER [J].
ADAMS, SS ;
BRESLOFF, P ;
MASON, CG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (03) :256-257
[7]  
ADAMS SS, 1969, ARCH INT PHARMACOD T, V178, P115
[8]  
Adams SS, 1970, RHEUMATOL PHYS M S10, V10, P9
[9]   CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J].
ALBERT, A .
NATURE, 1958, 182 (4633) :421-423
[10]   MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
12345678910